Glipizide Related Compound C

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	CS310361
Molecular Weight	445.54

A Girl With Permanent Neonatal Diabetes Due to KCNJ11 Mutation Presented With Mauriac Syndrome After Improper Adjustment in Sulfonylurea Dosage Over 6 Years

Rapeepun Chai-Udom, Taninee Sahakitrungruang, Suttipong Wacharasindhu, Vichit Supornsilchai

J Pediatr Endocrinol Metab. 2016 Sep 1;29(9):1095-101.

PMID: 27428845

A Randomised, Double-Blind, Trial of the Safety and Efficacy of Omarigliptin (A Once-Weekly DPP-4 Inhibitor) in Subjects With Type 2 Diabetes and Renal Impairment

Antonio Chacra, Ira Gantz, Geraldine Mendizabal, Lucila Durlach, Edward A O'Neill, Zachary Zimmer, Shailaja Suryawanshi, Samuel S Engel, Eseng Lai

Int J Clin Pract. 2017 Jun;71(6):e12955.

PMID: 28449320

Effect of Glipizide on Insulin Secretion and Insulin Metabolism in Obese Type II Diabetic Patients

E Bonora, F Pisani, R Micciolo, A Corgnati, M Muggeo

Diabetes Care. Nov-Dec 1987;10(6):687-91.

PMID: 3322723

Influence of Sulfonylureas on the Secretion, Disposal and Effect of Insulin

L O Almér, E Johansson, A Melander, E Wåhlin-Boll

Eur J Clin Pharmacol. 1982;22(1):27-32.

PMID: 7047169

Stoichiometry of Sulfonylurea-Induced ATP-sensitive Potassium Channel Closure

H Dörschner, E Brekardin, I Uhde, C Schwanstecher, M Schwanstecher

Mol Pharmacol. 1999 Jun;55(6):1060-6.

PMID: 10347249

* Products or Services Interested: Glipizide Related Compound C ()
* Your question
* Name
* Email
Verification Code

CAT	Size	Description	Price
CS310361-1	50MG	Pharmaceutical Secondary Standard; Certified Reference Material	Inquiry
CS310361-2	15MG	United States Pharmacopeia (USP) Reference Standard	Inquiry

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry